GB201522245D0 - Compounds useful as kinase inhibitors - Google Patents

Compounds useful as kinase inhibitors

Info

Publication number
GB201522245D0
GB201522245D0 GBGB1522245.8A GB201522245A GB201522245D0 GB 201522245 D0 GB201522245 D0 GB 201522245D0 GB 201522245 A GB201522245 A GB 201522245A GB 201522245 D0 GB201522245 D0 GB 201522245D0
Authority
GB
United Kingdom
Prior art keywords
kinase inhibitors
compounds useful
compounds
useful
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1522245.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharna PLC
Original Assignee
Redx Pharna PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharna PLC filed Critical Redx Pharna PLC
Priority to GBGB1522245.8A priority Critical patent/GB201522245D0/en
Publication of GB201522245D0 publication Critical patent/GB201522245D0/en
Priority to TNP/2018/000213A priority patent/TN2018000213A1/en
Priority to SG10202012498TA priority patent/SG10202012498TA/en
Priority to MX2021003478A priority patent/MX2021003478A/en
Priority to CN202111022492.0A priority patent/CN113636978A/en
Priority to CN201680073031.7A priority patent/CN108473481B/en
Priority to MX2018007267A priority patent/MX2018007267A/en
Priority to UAA202003795A priority patent/UA127863C2/en
Priority to SG11201805044WA priority patent/SG11201805044WA/en
Priority to RS20201291A priority patent/RS60982B1/en
Priority to CN202210311995.8A priority patent/CN114634447A/en
Priority to CN202210312076.2A priority patent/CN114621146A/en
Priority to CONC2018/0006164A priority patent/CO2018006164A2/en
Priority to JP2018532035A priority patent/JP6731483B2/en
Priority to CN202111022488.4A priority patent/CN113603645A/en
Priority to PE2018001143A priority patent/PE20181449A1/en
Priority to KR1020217003683A priority patent/KR20210018530A/en
Priority to ES16816363T priority patent/ES2828431T3/en
Priority to MA49809A priority patent/MA49809A1/en
Priority to MA54770A priority patent/MA54770B1/en
Priority to EA201891268A priority patent/EA035132B1/en
Priority to EP16816363.2A priority patent/EP3390395B1/en
Priority to CN202210312050.8A priority patent/CN114591242A/en
Priority to SI201630920T priority patent/SI3390395T1/en
Priority to CN202210310724.0A priority patent/CN114716381A/en
Priority to MDE20181001T priority patent/MD3390395T2/en
Priority to EP20194724.9A priority patent/EP3782994A1/en
Priority to UAA201807294A priority patent/UA122258C2/en
Priority to KR1020187020225A priority patent/KR102215792B1/en
Priority to LTEP16816363.2T priority patent/LT3390395T/en
Priority to CR20180367A priority patent/CR20180367A/en
Priority to PCT/GB2016/053968 priority patent/WO2017103611A1/en
Priority to CN202210311970.8A priority patent/CN114573510A/en
Priority to NZ743553A priority patent/NZ743553A/en
Priority to CN202210312064.XA priority patent/CN114605327A/en
Priority to DK16816363.2T priority patent/DK3390395T3/en
Priority to BR112018012341-2A priority patent/BR112018012341B1/en
Priority to US16/063,542 priority patent/US10695323B2/en
Priority to CA3008488A priority patent/CA3008488C/en
Priority to IL285976A priority patent/IL285976B2/en
Priority to HUE16816363A priority patent/HUE051921T2/en
Priority to PT168163632T priority patent/PT3390395T/en
Priority to MA055064A priority patent/MA55064A/en
Priority to PE2021001592A priority patent/PE20220502A1/en
Priority to MA42871A priority patent/MA42871B1/en
Priority to PE2021001581A priority patent/PE20220507A1/en
Priority to AU2016373530A priority patent/AU2016373530B2/en
Priority to IL259923A priority patent/IL259923B/en
Priority to PH12018501268A priority patent/PH12018501268A1/en
Priority to CL2018001591A priority patent/CL2018001591A1/en
Priority to ZA2018/04137A priority patent/ZA201804137B/en
Priority to US16/109,162 priority patent/US10342780B2/en
Priority to US16/113,661 priority patent/US10464905B2/en
Priority to HK18114157.0A priority patent/HK1263254A1/en
Priority to US15/930,657 priority patent/US10918622B2/en
Priority to JP2020116636A priority patent/JP7086140B2/en
Priority to IL276283A priority patent/IL276283B/en
Priority to CY20201101090T priority patent/CY1123561T1/en
Priority to HRP20201835TT priority patent/HRP20201835T1/en
Priority to US17/122,103 priority patent/US11471441B2/en
Priority to ZA2021/00544A priority patent/ZA202100544B/en
Priority to IL281067A priority patent/IL281067B/en
Priority to AU2021201811A priority patent/AU2021201811B2/en
Priority to AU2021225161A priority patent/AU2021225161B2/en
Priority to AU2021225162A priority patent/AU2021225162B2/en
Priority to ZA2021/07472A priority patent/ZA202107472B/en
Priority to ZA2021/07471A priority patent/ZA202107471B/en
Priority to US17/525,350 priority patent/US11826351B2/en
Priority to JP2022092275A priority patent/JP7419437B2/en
Priority to US18/362,249 priority patent/US20230372298A1/en
Priority to HUS2400003C priority patent/HUS2400003I1/en
Priority to FIC20240004C priority patent/FIC20240004I1/en
Ceased legal-status Critical Current

Links

GBGB1522245.8A 2015-12-16 2015-12-16 Compounds useful as kinase inhibitors Ceased GB201522245D0 (en)

Priority Applications (72)

Application Number Priority Date Filing Date Title
GBGB1522245.8A GB201522245D0 (en) 2015-12-16 2015-12-16 Compounds useful as kinase inhibitors
TNP/2018/000213A TN2018000213A1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
SG10202012498TA SG10202012498TA (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
MX2021003478A MX2021003478A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors.
CN202111022492.0A CN113636978A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN201680073031.7A CN108473481B (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
MX2018007267A MX2018007267A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors.
UAA202003795A UA127863C2 (en) 2015-12-16 2016-12-16 COMPOUNDS USABLE AS KINASE INHIBITORS
SG11201805044WA SG11201805044WA (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
RS20201291A RS60982B1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210311995.8A CN114634447A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210312076.2A CN114621146A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CONC2018/0006164A CO2018006164A2 (en) 2015-12-16 2016-12-16 Useful compounds as kinase inhibitors
JP2018532035A JP6731483B2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202111022488.4A CN113603645A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
PE2018001143A PE20181449A1 (en) 2015-12-16 2016-12-16 USEFUL COMPOUNDS AS KINASE INHIBITORS
KR1020217003683A KR20210018530A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
ES16816363T ES2828431T3 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
MA49809A MA49809A1 (en) 2015-12-16 2016-12-16 Compounds used as kinase inhibitors
MA54770A MA54770B1 (en) 2015-12-16 2016-12-16 COMPOUNDS USED AS KINASE INHIBITORS
EA201891268A EA035132B1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
EP16816363.2A EP3390395B1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210312050.8A CN114591242A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
SI201630920T SI3390395T1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210310724.0A CN114716381A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
MDE20181001T MD3390395T2 (en) 2015-12-16 2016-12-16 Ccompounds useful as kinase inhibitors
EP20194724.9A EP3782994A1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
UAA201807294A UA122258C2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
KR1020187020225A KR102215792B1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
LTEP16816363.2T LT3390395T (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CR20180367A CR20180367A (en) 2015-12-16 2016-12-16 USEFUL COMPOUNDS AS KINASE INHIBITORS
PCT/GB2016/053968 WO2017103611A1 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210311970.8A CN114573510A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
NZ743553A NZ743553A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CN202210312064.XA CN114605327A (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
DK16816363.2T DK3390395T3 (en) 2015-12-16 2016-12-16 Compounds that can be used as kinase inhibitors
BR112018012341-2A BR112018012341B1 (en) 2015-12-16 2016-12-16 KINASE INHIBITORS, THEIR USES, AND PHARMACEUTICAL COMPOSITION
US16/063,542 US10695323B2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
CA3008488A CA3008488C (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
IL285976A IL285976B2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
HUE16816363A HUE051921T2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
PT168163632T PT3390395T (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
MA055064A MA55064A (en) 2015-12-16 2016-12-16 COMPOUNDS USED AS KINASE INHIBITORS
PE2021001592A PE20220502A1 (en) 2015-12-16 2016-12-16 COMPOUNDS USEFUL AS KINASE INHIBITORS
MA42871A MA42871B1 (en) 2015-12-16 2016-12-16 Compounds used as bruton tyrosine kinase (btk) inhibitors
PE2021001581A PE20220507A1 (en) 2015-12-16 2016-12-16 COMPOUNDS USEFUL AS KINASE INHIBITORS
AU2016373530A AU2016373530B2 (en) 2015-12-16 2016-12-16 Compounds useful as kinase inhibitors
IL259923A IL259923B (en) 2015-12-16 2018-06-10 Compounds useful as kinase inhibitors
PH12018501268A PH12018501268A1 (en) 2015-12-16 2018-06-13 Compounds useful as kinase inhibitors
CL2018001591A CL2018001591A1 (en) 2015-12-16 2018-06-14 Useful compounds as kinase inhibitors.-
ZA2018/04137A ZA201804137B (en) 2015-12-16 2018-06-20 Compounds useful as kinase inhibitors
US16/109,162 US10342780B2 (en) 2015-12-16 2018-08-22 Compounds useful as kinase inhibitors
US16/113,661 US10464905B2 (en) 2015-12-16 2018-08-27 Compounds useful as kinase inhibitors
HK18114157.0A HK1263254A1 (en) 2015-12-16 2018-11-06 Compounds useful as kinase inhibitors
US15/930,657 US10918622B2 (en) 2015-12-16 2020-05-13 Compounds useful as kinase inhibitors
JP2020116636A JP7086140B2 (en) 2015-12-16 2020-07-06 Compounds useful as kinase inhibitors
IL276283A IL276283B (en) 2015-12-16 2020-07-26 Compounds useful as kinase inhibitors
CY20201101090T CY1123561T1 (en) 2015-12-16 2020-11-16 COMPOUNDS USEFUL AS KINASE INHIBITORS
HRP20201835TT HRP20201835T1 (en) 2015-12-16 2020-11-19 Compounds useful as kinase inhibitors
US17/122,103 US11471441B2 (en) 2015-12-16 2020-12-15 Compounds useful as kinase inhibitors
ZA2021/00544A ZA202100544B (en) 2015-12-16 2021-01-26 Compounds useful as kinase inhibitors
IL281067A IL281067B (en) 2015-12-16 2021-02-24 Compounds useful as kinase inhibitors
AU2021201811A AU2021201811B2 (en) 2015-12-16 2021-03-23 Compounds useful as kinase inhibitors
AU2021225161A AU2021225161B2 (en) 2015-12-16 2021-08-31 Compounds useful as kinase inhibitors
AU2021225162A AU2021225162B2 (en) 2015-12-16 2021-08-31 Compounds useful as kinase inhibitors
ZA2021/07472A ZA202107472B (en) 2015-12-16 2021-10-05 Compounds useful as kinase inhibitors
ZA2021/07471A ZA202107471B (en) 2015-12-16 2021-10-05 Compounds useful as kinase inhibitors
US17/525,350 US11826351B2 (en) 2015-12-16 2021-11-12 Compounds useful as kinase inhibitors
JP2022092275A JP7419437B2 (en) 2015-12-16 2022-06-07 Compounds useful as kinase inhibitors
US18/362,249 US20230372298A1 (en) 2015-12-16 2023-07-31 Compounds useful as kinase inhibitors
HUS2400003C HUS2400003I1 (en) 2015-12-16 2024-02-27 Compounds useful as kinase inhibitors
FIC20240004C FIC20240004I1 (en) 2015-12-16 2024-03-01 Pirtobrutinib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1522245.8A GB201522245D0 (en) 2015-12-16 2015-12-16 Compounds useful as kinase inhibitors

Publications (1)

Publication Number Publication Date
GB201522245D0 true GB201522245D0 (en) 2016-02-03

Family

ID=55311104

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1522245.8A Ceased GB201522245D0 (en) 2015-12-16 2015-12-16 Compounds useful as kinase inhibitors

Country Status (2)

Country Link
GB (1) GB201522245D0 (en)
MA (2) MA54770B1 (en)

Also Published As

Publication number Publication date
MA54770B1 (en) 2023-06-28
MA42871A1 (en) 2019-04-30
MA54770A1 (en) 2022-06-30
MA42871B1 (en) 2020-06-30

Similar Documents

Publication Publication Date Title
HUS2400003I1 (en) Compounds useful as kinase inhibitors
ZA201700115B (en) Aminopyridazinone compounds as protein kinase inhibitors
RS63359B1 (en) Heterocyclic compounds as pi3k-gamma inhibitors
IL255750A (en) Heterocyclic compounds as kinase inhibitors
IL268614A (en) Aminotriazolopyridines as kinase inhibitors
IL274207A (en) Aminoimidazopyridazines as kinase inhibitors
IL266789A (en) Heterocyclic compounds as kinase inhibitors
IL266150A (en) Amide compounds as kinase inhibitors
EP3102571A4 (en) Substituted pyrimidines useful as egfr-t790m kinase inhibitors
HK1253576A1 (en) Pyrropyrimidine compounds as mnks inhibitors
GB201613945D0 (en) Compounds useful as kinase inhibitors
GB201522245D0 (en) Compounds useful as kinase inhibitors
GB201519381D0 (en) Kinase inhibitors
GB201519382D0 (en) Kinase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)